For instance, Ren et al[15] reported that high GPX8 expression was associated with worse overall survival and disease-free survival in COAD patients, while Zhang et al[16] found that high GPX8 expression was correlated with unfavorable survival outcomes in STAD patients. This evidence concerns the gene GPX8 and gastric adenocarcinoma.